CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa, Junctional Interventions: Device: CACIPLIQ20; Drug: Placebo Sponsors: Organ, Tissue, Regeneration, Repair and Replacement; Euraxi Pharma; ARANZ Medical Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials